1. Home
  2. ARDT vs IDYA Comparison

ARDT vs IDYA Comparison

Compare ARDT & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDT
  • IDYA
  • Stock Information
  • Founded
  • ARDT 2001
  • IDYA 2015
  • Country
  • ARDT United States
  • IDYA United States
  • Employees
  • ARDT N/A
  • IDYA N/A
  • Industry
  • ARDT
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARDT
  • IDYA Health Care
  • Exchange
  • ARDT NYSE
  • IDYA Nasdaq
  • Market Cap
  • ARDT 2.8B
  • IDYA 2.6B
  • IPO Year
  • ARDT 2024
  • IDYA 2019
  • Fundamental
  • Price
  • ARDT $16.63
  • IDYA $26.64
  • Analyst Decision
  • ARDT Buy
  • IDYA Strong Buy
  • Analyst Count
  • ARDT 10
  • IDYA 12
  • Target Price
  • ARDT $22.30
  • IDYA $53.08
  • AVG Volume (30 Days)
  • ARDT 264.5K
  • IDYA 750.9K
  • Earning Date
  • ARDT 11-06-2024
  • IDYA 11-04-2024
  • Dividend Yield
  • ARDT N/A
  • IDYA N/A
  • EPS Growth
  • ARDT N/A
  • IDYA N/A
  • EPS
  • ARDT 0.64
  • IDYA N/A
  • Revenue
  • ARDT $5,705,817,000.00
  • IDYA $3,922,000.00
  • Revenue This Year
  • ARDT $10.07
  • IDYA N/A
  • Revenue Next Year
  • ARDT $7.76
  • IDYA $158.10
  • P/E Ratio
  • ARDT $25.77
  • IDYA N/A
  • Revenue Growth
  • ARDT 11.23
  • IDYA N/A
  • 52 Week Low
  • ARDT $14.58
  • IDYA $26.41
  • 52 Week High
  • ARDT $20.72
  • IDYA $47.74
  • Technical
  • Relative Strength Index (RSI)
  • ARDT N/A
  • IDYA 33.96
  • Support Level
  • ARDT N/A
  • IDYA $27.52
  • Resistance Level
  • ARDT N/A
  • IDYA $32.67
  • Average True Range (ATR)
  • ARDT 0.00
  • IDYA 1.44
  • MACD
  • ARDT 0.00
  • IDYA -0.04
  • Stochastic Oscillator
  • ARDT 0.00
  • IDYA 3.75

About ARDT ARDENT HEALTH PARTNERS INC

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

Share on Social Networks: